1.
Begna KH, Abdallah NH, Janania-Martinez M, Mangaonkar AA, Rangan A, Herrick JL, Gangat N. Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant. haematol [Internet]. 2023Sep.14 [cited 2024Mar.3];109(2):689-92. Available from: https://haematologica.org/article/view/haematol.2023.283740